Gregory Stock

From Wikipedia, the free encyclopedia

Gregory Stock is a biophysicist, best-selling science writer, and the director of the Program on Medicine, Technology, and Society at UCLA’s School of Public Health. He has often focused on the implications for society, medicine, and business of the human genome project and associated developments in molecular genetics and bioinformatics.

Stock is also the CEO of Signum Biosciences, a biotech company developing therapeutics for Alzheimer’s disease, sits on the editorial board of the American Journal of Bioethics, and is a professor in the Department of Psychiatry and Biobehavior at UCLA. Stock's doctorate is in biophysics from John Hopkins University.

[edit] Works

Some of his works include:

• The Book of Questions (1987) (a #1 New York Times Bestseller).[1]
• Metaman (1993).
• Engineering the Human Germline: An Exploration of the Science and Ethics of Altering the Genes We Pass to Our Children (2000, Oxford University Press) (Co-editor with John Campbell).
• Redesigning Humans: Our Inevitable Genetic Future (2002) (See reviews from the NYTimes, and [2]). The book won the Kistler Book Prize for Science books and was nominated for a Wired Rave Award.

[edit] External links

• Wall Street Journal Profile of Stock (June, 2002).